RoosterBio Inc.

📍 Frederick, United States🗓 Founded 2013👥 53 employees💰 Last funded Jul 2019
Biotechnology Research🌐 roosterbio.com
Website LinkedIn
RoosterBio accelerates human mesenchymal stem/stromal cell (hMSC) and exosome/extracellular vesicle (EV) product and process development to fuel the rapid implementation of scalable advanced therapies. Our high-quality hMSCs, bioprocess media, genetic engineering tools, and exosome production solutions are paired with expert bioprocessing knowledge to progress therapeutic developers from concept to first-in-human testing and commercial manufacturing at reduced cost and increased productivity. With optimized, scalable processes, Type II Drug Master Files, and cGMP products, we have enabled therapeutic programs to traverse their path to clinical translation in under one year. RoosterBio is driven by our clients success and creating a world where safe and effective advanced therapies are rapidly developed and widely available on a global scale.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2013
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in RoosterBio Inc.?
RoosterBio Inc. has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did RoosterBio Inc. last raise funding?
The most recent investment in RoosterBio Inc. recorded on gritt.io was in July 2019.
When was RoosterBio Inc. founded?
RoosterBio Inc. was founded in 2013.
What industry is RoosterBio Inc. in?
RoosterBio Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is RoosterBio Inc. based?
RoosterBio Inc. is headquartered in Frederick, United States.